Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Methods of Nuclear Reprogramming01:24

Methods of Nuclear Reprogramming

2.3K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
2.3K
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

2.9K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.9K
Introduction to Nuclear Reprogramming01:14

Introduction to Nuclear Reprogramming

2.4K
Nuclear reprogramming is the process of switching gene expression of one cell type to that of another cell type, usually from a differentiated cell state to an undifferentiated cell state. Differentiation occurs during processes such as development and morphogenesis, tissue regeneration, and malignancy. Cells can also be artificially induced to reprogram their gene expression by techniques such as nuclear transfer, induced pluripotency, and cell fusion. Such techniques have many applications in...
2.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Classification of indeterminate and off-target cell types within human kidney organoid differentiation.

iScience·2026
Same author

Application of spatial transcriptomics across organoids for a high-resolution, spatial whole-transcriptome benchmarking dataset.

iScience·2026
Same author

In vitro modeling of renal injury-induced cardiac effects using human iPSC-derived organoids.

Cell communication and signaling : CCS·2026
Same author

The emergence of multiple testicular cell lineages in human stem cell-derived testis-like organoids.

Development (Cambridge, England)·2026
Same author

In vitro plasticity between ureteric epithelial and distal nephron identity and maturity is controlled by extracellular signals.

Developmental biology·2026
Same author

Advances and continuing challenges in differentiation of stem cells to human kidney tissue.

Nature reviews. Nephrology·2025

Related Experiment Video

Updated: Apr 7, 2026

Author Spotlight: Optimizing iPSC Differentiation for Efficient Production to Generate Kidney Organoids
07:22

Author Spotlight: Optimizing iPSC Differentiation for Efficient Production to Generate Kidney Organoids

Published on: September 1, 2023

4.0K

Direct transcriptional reprogramming to nephron progenitors.

Jessica M Vanslambrouck1, Melissa H Little2

  • 1The Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia.

Current Opinion in Genetics & Development
|July 16, 2015
PubMed
Summary

Direct reprogramming can create kidney cells for therapy, but optimal conditions for maintaining these nephron progenitors are unclear. This study questions their definition and explores alternative kidney reprogramming methods.

More Related Videos

Reprogramming Mouse Embryonic Fibroblasts with Transcription Factors to Induce a Hemogenic Program
11:00

Reprogramming Mouse Embryonic Fibroblasts with Transcription Factors to Induce a Hemogenic Program

Published on: December 16, 2016

7.8K
Generation of Induced Pluripotent Stem Cells from Muscular Dystrophy Patients: Efficient Integration-free Reprogramming of Urine Derived Cells
09:11

Generation of Induced Pluripotent Stem Cells from Muscular Dystrophy Patients: Efficient Integration-free Reprogramming of Urine Derived Cells

Published on: January 28, 2015

11.8K

Related Experiment Videos

Last Updated: Apr 7, 2026

Author Spotlight: Optimizing iPSC Differentiation for Efficient Production to Generate Kidney Organoids
07:22

Author Spotlight: Optimizing iPSC Differentiation for Efficient Production to Generate Kidney Organoids

Published on: September 1, 2023

4.0K
Reprogramming Mouse Embryonic Fibroblasts with Transcription Factors to Induce a Hemogenic Program
11:00

Reprogramming Mouse Embryonic Fibroblasts with Transcription Factors to Induce a Hemogenic Program

Published on: December 16, 2016

7.8K
Generation of Induced Pluripotent Stem Cells from Muscular Dystrophy Patients: Efficient Integration-free Reprogramming of Urine Derived Cells
09:11

Generation of Induced Pluripotent Stem Cells from Muscular Dystrophy Patients: Efficient Integration-free Reprogramming of Urine Derived Cells

Published on: January 28, 2015

11.8K

Area of Science:

  • Cell biology
  • Regenerative medicine
  • Developmental biology

Background:

  • Direct cell reprogramming offers a promising route for generating specific cell types for therapeutic applications.
  • This process typically involves activating key transcription factors and modifying chromatin structure.
  • Previous studies have shown direct reprogramming of mature renal epithelial cells to a nephron progenitor state.

Purpose of the Study:

  • To evaluate the definition and suitability of nephron progenitors generated via direct reprogramming as a therapeutic endpoint.
  • To investigate alternative strategies for direct reprogramming towards kidney cell fates.

Main Methods:

  • Analysis of existing literature on direct cell reprogramming and kidney progenitor cell biology.
  • Examination of the criteria used to define reprogrammed nephron progenitor states.
  • Exploration of potential alternative cell sources and reprogramming protocols for kidney regeneration.

Main Results:

  • The definition and maintenance of directly reprogrammed nephron progenitors remain incompletely understood, posing challenges for clinical translation.
  • Current knowledge gaps exist regarding the optimal conditions required to sustain these reprogrammed cells.
  • Alternative reprogramming approaches for generating kidney cells may offer viable therapeutic avenues.

Conclusions:

  • Further research is needed to rigorously define and validate directly reprogrammed nephron progenitor cells.
  • Optimizing culture conditions is critical for the therapeutic application of reprogrammed kidney cells.
  • Exploring diverse reprogramming strategies is essential for advancing kidney regenerative medicine.